Biofrontera Pharma GmbH is a 100% subsidiary of Biofrontera AG and is responsible for the manufacturing, licensing, and marketing of dermatological products. The company primarily distributes the drug Ameluz® for photodynamic therapy as well as the associated BF-RhodoLED® lamp series for the treatment of actinic keratosis. With its own sales organizations in Germany, Spain, and the United Kingdom, as well as international licensing partners, the company addresses the dermatology market. The company utilizes patents and know-how from Biofrontera Bioscience GmbH for its commercial activities.
die Entdeckung, die Entwicklung und der Vertrieb von Pharmazeutika, Medizinprodukten und Kosmetika.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 57309 (as of 24 August 2026)
Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 57309 (as of 24 August 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 57309 (as of 24 August 2026)
GHD GesundHeits GmbH Deutschland Compounding Greven
Greven · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
MEDINORM Medizintechnik GmbH
Spiesen-Elversberg · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sano Arzneimittelfabrik Gesellschaft mit beschränkter Haftung
Renningen · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sign in to view detailed salary and cost trends.
